Dorocubicel for treating haematological cancer when a suitable donor is unavailable for an allogeneic haematopoietic stem cell transplant [ID6521] Technology appraisal guidance Dostarlimab and ...
Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age who had symptoms before 13 years [TSID12046] Technology appraisal guidance Dupilumab for treating eosinophilic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback